Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00875628 · ClinicalTrials.gov registry record · Phase 1
A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers
A Phase 1 study, sponsored by Pfizer.
- Terminated
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00875628 is a Phase 1 study that was terminated before completion, run by Pfizer. The registered enrollment target is 24 participants.
The verdict
NCT00875628, a Phase 1 study, was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
Investigation of safety, tolerability, and pharmacokinetics of PF-00868554 following multiple oral administrations of PF-00868554 in Japanese healthy adult volunteers.
Interventions
- DRUG PF-00868554 or Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00875628
The ClinicalTrials.gov registry entry for NCT00875628 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PF-00868554 or Placebo is the first listed.
NCT00875628 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00875628 about?
NCT00875628 is a clinical study titled "A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers". Investigation of safety, tolerability, and pharmacokinetics of PF-00868554 following multiple oral administrations of PF-00868554 in Japanese healthy adult volunteers.
What is the current status of trial NCT00875628?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2009-04. Estimated completion is 2009-04.
What interventions are being tested in trial NCT00875628?
The interventions under investigation include: PF-00868554 or Placebo (DRUG).
Who is sponsoring clinical trial NCT00875628?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.